FDA Inspection 1174996 — International Pharmaceutical Research Center (IPRC)
The FDA completed an inspection of International Pharmaceutical Research Center (IPRC) on Jul 7, 2022 in Amman. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 7, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Amman (Jordan)
Additional Details
Clinical BA/BE